Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | Erlotinib | 0.0033113 | uM | 9 | 625.00 | 414.82 | 970.00 | 929.25 | 1.0439 | 1.0751 |
| SK-BR-3 | Linsitinib | 0.1 | uM | 9 | 625.00 | 414.82 | 870.00 | 929.25 | 0.9362 | 0.8899 |
| SK-BR-3 | Lapatinib | 0.1 | uM | 9 | 625.00 | 414.82 | 566.00 | 929.25 | 0.6091 | 0.3061 |
| SK-BR-3 | 0 | uM | 9 | 625.00 | 414.82 | 1442.00 | 929.25 | 1.5518 | 1.9177 | |
| SK-BR-3 | 17-AAG | 0.000066069 | uM | 9 | 625.00 | 414.82 | 972.00 | 929.25 | 1.0460 | 1.0788 |
| SK-BR-3 | 0 | uM | 9 | 625.00 | 414.82 | 1112.00 | 929.25 | 1.1967 | 1.3337 | |
| SK-BR-3 | Linsitinib | 0.01 | uM | 9 | 625.00 | 414.82 | 1010.00 | 929.25 | 1.0869 | 1.1485 |
| SK-BR-3 | 17-AAG | 0.1 | uM | 9 | 625.00 | 414.82 | 332.00 | 929.25 | 0.3573 | -0.1742 |
| SK-BR-3 | Lapatinib | 0.01 | uM | 9 | 625.00 | 414.82 | 787.00 | 929.25 | 0.8469 | 0.7339 |
| SK-BR-3 | Lapatinib | 0.31623 | uM | 9 | 625.00 | 414.82 | 389.00 | 929.25 | 0.4186 | -0.0537 |
| SK-BR-3 | 17-AAG | 0.31623 | uM | 9 | 625.00 | 414.82 | 345.00 | 929.25 | 0.3713 | -0.1465 |
| SK-BR-3 | Erlotinib | 0.1 | uM | 9 | 625.00 | 414.82 | 1090.00 | 929.25 | 1.1730 | 1.2939 |
| SK-BR-3 | 0 | uM | 9 | 625.00 | 414.82 | 1029.00 | 929.25 | 1.1073 | 1.1832 | |
| SK-BR-3 | Erlotinib | 19.9526 | uM | 9 | 625.00 | 414.82 | 496.00 | 929.25 | 0.5338 | 0.1660 |
| SK-BR-3 | Lapatinib | 0.031623 | uM | 9 | 625.00 | 414.82 | 649.00 | 929.25 | 0.6984 | 0.4691 |
| SK-BR-3 | Lapatinib | 0.0016596 | uM | 9 | 625.00 | 414.82 | 994.00 | 929.25 | 1.0697 | 1.1192 |
| SK-BR-3 | 17-AAG | 0.031623 | uM | 9 | 625.00 | 414.82 | 325.00 | 929.25 | 0.3497 | -0.1892 |
| SK-BR-3 | 0 | uM | 9 | 625.00 | 414.82 | 713.00 | 929.25 | 0.7673 | 0.5928 | |
| SK-BR-3 | 0 | uM | 9 | 1250.00 | 830.55 | 1970.00 | 1962.75 | 1.0037 | 1.0060 | |
| SK-BR-3 | Erlotinib | 0.01 | uM | 9 | 1250.00 | 830.55 | 1728.00 | 1962.75 | 0.8804 | 0.8049 |
| SK-BR-3 | 17-AAG | 0.000302 | uM | 9 | 1250.00 | 830.55 | 1924.00 | 1962.75 | 0.9803 | 0.9681 |
| SK-BR-3 | Erlotinib | 0.31623 | uM | 9 | 1250.00 | 830.55 | 2211.00 | 1962.75 | 1.1265 | 1.2015 |
| SK-BR-3 | Erlotinib | 1 | uM | 9 | 1250.00 | 830.55 | 2324.00 | 1962.75 | 1.1841 | 1.2917 |
| SK-BR-3 | Lapatinib | 10 | uM | 9 | 1250.00 | 830.55 | 554.00 | 1962.75 | 0.2823 | -0.2785 |
| SK-BR-3 | Linsitinib | 0.031623 | uM | 9 | 1250.00 | 830.55 | 2161.00 | 1962.75 | 1.1010 | 1.1613 |